China Approves Its First AI-Developed Drug
Summary
China's National Medical Products Administration has approved the country's first Class 1 innovative drug developed using artificial intelligence.
Prepared by the newsroom with AI assistance; the original link is always provided
China's National Medical Products Administration (NMPA) has granted market approval for the country's first Class 1 innovative medicine developed with the help of artificial intelligence, Westlake University announced.
The drug, named Mprosevir, was co-developed by Westlake University and its partners.
The development process, from the initial discovery of the drug candidate to the completion of clinical trials, took three and a half years.
Source: Kursiv
Read the original →Latest news
Bank CenterCredit Repurchases Shares for 18.2B Tenge on KASE
Bank CenterCredit JSC has repurchased 4.1 million of its common shares on the Kazakhstan Stock Exchange for 18.2 billion tenge.
Source: KASE
Home Credit Bank Bonds Added to KASE T+ List
Starting October 8, Home Credit Bank bonds (KZQ000001213, HCBNe1) will be included in the KASE T+ List.
Source: KASE
KASE Publishes Member Activity Rankings for September 2026
Kazakhstan Stock Exchange has released its exchange member activity rankings for September 2026 on its official website.
Source: KASE
KASE Index rises 0.25% to 7,862.81 points
On October 7, the KASE Index climbed by 0.25% to settle at 7,862.81 points.
Source: KASE